Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
BMJ Global Health|March 19, 2021
Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countriesRichard Lilford, Dmitri Nepogodiev, Peter J Chilton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2010
Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) studyBorislava Mihaylova, Richard Pitman, Douglas Tincello, et al.
The Lancet. Infectious Diseases|January 25, 2014
Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?Martina Penazzato, Paul Revill, Andrew J Prendergast, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 30, 2010
What do international pharmacoeconomic guidelines say about economic data transferability?Marco Barbieri, Michael Drummond, Frans Rutten, et al.
Heart (British Cardiac Society)|June 11, 2009
Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty projectAllan Wailoo, Steve Goodacre, Fiona Sampson, et al.
International Journal of Technology Assessment in Health Care|April 16, 2010
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United KingdomClaire McKenna, Neil Hawkins, Karl Claxton, et al.
Pharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.
Orphanet Journal of Rare Diseases|March 19, 2025
Development of the natural history component of an early economic model for primary sclerosing cholangitisChristopher Bowlus, Cynthia Levy, Kris V Kowdley, et al.
Trials|August 9, 2019
The HOME Study: study protocol for a randomised controlled trial comparing the addition of Proactive Psychological Medicine to usual care, with usual care alone, on the time spent in hospital by older acute hospital inpatientsJane Walker, Katy Burke, Mark Toynbee, et al.
Frontiers in Public Health|November 17, 2022
Assessing the potential of HTA to inform resource allocation decisions in low-income settings: The case of MalawiFrancesco Ramponi, Pakwanja Twea, Benson Chilima, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
BMJ Global Health|March 19, 2021
Methodological issues in economic evaluations of emergency transport systems in low-income and middle-income countriesRichard Lilford, Dmitri Nepogodiev, Peter J Chilton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2010
Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) studyBorislava Mihaylova, Richard Pitman, Douglas Tincello, et al.
The Lancet. Infectious Diseases|January 25, 2014
Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?Martina Penazzato, Paul Revill, Andrew J Prendergast, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 30, 2010
What do international pharmacoeconomic guidelines say about economic data transferability?Marco Barbieri, Michael Drummond, Frans Rutten, et al.
Heart (British Cardiac Society)|June 11, 2009
Primary angioplasty versus thrombolysis for acute ST-elevation myocardial infarction: an economic analysis of the National Infarct Angioplasty projectAllan Wailoo, Steve Goodacre, Fiona Sampson, et al.
International Journal of Technology Assessment in Health Care|April 16, 2010
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United KingdomClaire McKenna, Neil Hawkins, Karl Claxton, et al.
Pharmacoeconomics|June 18, 2005
Incorporation of uncertainty in health economic modelling studiesAnthony O'Hagan, Christopher McCabe, Ron Akehurst, et al.
Orphanet Journal of Rare Diseases|March 19, 2025
Development of the natural history component of an early economic model for primary sclerosing cholangitisChristopher Bowlus, Cynthia Levy, Kris V Kowdley, et al.
Trials|August 9, 2019
The HOME Study: study protocol for a randomised controlled trial comparing the addition of Proactive Psychological Medicine to usual care, with usual care alone, on the time spent in hospital by older acute hospital inpatientsJane Walker, Katy Burke, Mark Toynbee, et al.
Frontiers in Public Health|November 17, 2022
Assessing the potential of HTA to inform resource allocation decisions in low-income settings: The case of MalawiFrancesco Ramponi, Pakwanja Twea, Benson Chilima, et al.
Pageof 18